Infarct-related artery only revascularization versus multi-vessel revascularization for patients with Killip I-IV acute myocardial infarction and multivessel disease

References

• Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677–1684. doi: 10.1001/jama.2011.522.
   PubMed Web of Science ®Google Scholar
• Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. European Heart J. 2010;31:943–957. doi: 10.1093/eurheartj/ehp492.
   PubMed Web of Science ®Google Scholar
• Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA. 2005;293(12):1501–1508. doi: 10.1001/jama.293.12.1501.
   PubMed Web of Science ®Google Scholar
• Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart. 2006;92(5):641–649. doi: 10.1136/hrt.2005.061622.
   PubMed Web of Science ®Google Scholar
• van der Schaaf RJ, Timmer JR, Ottervanger JP, et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart. 2006;92(12):1760–1763. doi: 10.1136/hrt.2005.086058.
   PubMed Web of Science ®Google Scholar
• Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart. 2005;91(12):1541–1544. doi: 10.1136/hrt.2004.054692.
   PubMed Web of Science ®Google Scholar
• Omer MA, Brilakis ES, Kennedy KF, et al. Multivessel versus culprit-vessel percutaneous coronary intervention in patients with non-ST-segment elevation myocardial infarction and cardiogenic shock. JACC Cardiovasc Interv. 2021;14(10):1067–1078. doi: 10.1016/j.jcin.2021.02.021.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Wood DA, Meeks B, et al. Design and rationale of the COMPLETE trial: a randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction. Am Heart J. 2019;215:157–166. doi: 10.1016/j.ahj.2019.06.006.
   PubMed Web of Science ®Google Scholar
• Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369(12):1115–1123. doi: 10.1056/NEJMoa1305520.
   PubMed Web of Science ®Google Scholar
• Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65(10):963–972. doi: 10.1016/j.jacc.2014.12.038.
   PubMed Web of Science ®Google Scholar
• Gershlick AH, Banning AS, Parker E, et al. Long-term follow-up of complete versus lesion-only revascularization in STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2019;74(25):3083–3094. doi: 10.1016/j.jacc.2019.10.033.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381(15):1411–1421. doi: 10.1056/NEJMoa1907775.
   PubMed Web of Science ®Google Scholar
• Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386(9994):665–671. doi: 10.1016/s0140-6736(15)60648-1.
   PubMed Web of Science ®Google Scholar
• Tarantini G, D’Amico G, Brener SJ, et al. Survival after varying revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a pairwise and network meta-analysis. JACC Cardiovasc Interv. 2016;9(17):1765–1776. doi: 10.1016/j.jcin.2016.06.012.
   PubMed Web of Science ®Google Scholar
• Bainey KR, Welsh RC, Toklu B, et al. Complete vs culprit-only percutaneous coronary intervention in STEMI with multivessel disease: a meta-analysis and trial sequential analysis of randomized trials. Can J Cardiol. 2016;32(12):1542–1551. doi: 10.1016/j.cjca.2016.02.077.
   PubMed Web of Science ®Google Scholar
• Elgendy IY, Mahmoud AN, Kumbhani DJ, et al. Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017;10(4):315–324. doi: 10.1016/j.jcin.2016.11.047.
   PubMed Web of Science ®Google Scholar
• Windecker S, Stortecky S, Stefanini GG, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348(jun23 8):g3859–g3859. doi: 10.1136/bmj.g3859.
   PubMedGoogle Scholar
• Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, et al. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J. 2004;25(5):401–408. doi: 10.1016/j.ehj.2003.12.017.
   PubMed Web of Science ®Google Scholar
• Kubo T, Imanishi T, Kashiwagi M, et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol. 2010;105(3):318–322. doi: 10.1016/j.amjcard.2009.09.032.
   PubMed Web of Science ®Google Scholar
• Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–2432. doi: 10.1056/NEJMoa1710261.
   PubMed Web of Science ®Google Scholar
• Thiele H, Akin I, Sandri M, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379(18):1699–1710. doi: 10.1056/NEJMoa1808788.
   PubMed Web of Science ®Google Scholar
• McNeice A, Nadra IJ, Robinson SD, et al. The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: insights from the British Columbia cardiac registry. Catheter Cardiovasc Interv. 2018;92(5):E356–e367. doi: 10.1002/ccd.27648.
   PubMed Web of Science ®Google Scholar
• Lee JM, Rhee TM, Kim HK, et al. Comparison of long-term clinical outcome between multivessel percutaneous coronary intervention versus infarct-related artery-only revascularization for patients with ST-segment-elevation myocardial infarction with cardiogenic shock. J Am Heart Assoc. 2019;8:e013870.
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–235. doi: 10.1056/NEJMoa1002358.
   PubMed Web of Science ®Google Scholar
• Diletti R, den Dekker WK, Bennett J, et al. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401(10383):1172–1182. doi: 10.1016/S0140-6736(23)00351-3.
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Ali ZA, et al. Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque. J Am Coll Cardiol. 2020;76(20):2289–2301. doi: 10.1016/j.jacc.2020.09.547.
   PubMed Web of Science ®Google Scholar
• Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J. 2012;33(6):768–775. doi: 10.1093/eurheartj/ehr471.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Morimoto T, Shiomi H, et al. Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry). Catheter Cardiovasc Interv. 2018;92(3):455–463. doi: 10.1002/ccd.27330.
   PubMed Web of Science ®Google Scholar